aluates Reports

$ 0.0

Automative

Global Dendritic Cell Cancer Vaccine Immunotherapy Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-6D14388

Global Dendritic Cell Cancer Vaccine Immunotherapy Market Research Report 2023

BUY CHAPTERS

Global Dendritic Cell Cancer Vaccine Immunotherapy Market Research Report 2025

Code: QYRE-Auto-6D14388

Report

July 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Lineage Cell Therapeutics

AVAX Technologies

DCPrime

Gradalis Inc

Heat Biologics

ImmunoCellular Therapeutics

Immunicum

MolecuVax

Northwest Biotherapeutics

Pique Therapeutics

Regeneus

Tessa Therapeutics

Vaccinogen

XEME Biopharma

Dendritic Cell Cancer Vaccine Immunotherapy Market Size

The global market for Dendritic Cell Cancer Vaccine Immunotherapy was valued at US$ 744 million in the year 2024 and is projected to reach a revised size of US$ 1446 million by 2031, growing at a CAGR of 10.1% during the forecast period.

Dendritic Cell Cancer Vaccine Immunotherapy Market

Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These cells have proficiency of capturing and processing tumor antigens, which activates expression of lymphocyte co-stimulatory molecules. Consequently, it results in secretion of cytokines to initiate immune response. Over 60 dendritic cell and tumor cell cancer vaccines are currently in clinical / preclinical stages of development; 70% of the pipeline comprises of dendritic cell cancer vaccines.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Dendritic Cell Cancer Vaccine Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dendritic Cell Cancer Vaccine Immunotherapy.

The Dendritic Cell Cancer Vaccine Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dendritic Cell Cancer Vaccine Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dendritic Cell Cancer Vaccine Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dendritic Cell Cancer Vaccine Immunotherapy Market Report

Report Metric	Details
Report Name	Dendritic Cell Cancer Vaccine Immunotherapy Market
Accounted market size in year	US$ 744 million
Forecasted market size in 2031	US$ 1446 million
CAGR	10.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Provenge Apceden CreaVax Others
Segment by Application	Pediatrics Adults
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lineage Cell Therapeutics, AVAX Technologies, DCPrime, Gradalis, Heat Biologics, ImmunoCellular Therapeutics, Immunicum, MolecuVax, Northwest Biotherapeutics, Pique Therapeutics, Regeneus, Tessa Therapeutics, Vaccinogen, XEME Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dendritic Cell Cancer Vaccine Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Dendritic Cell Cancer Vaccine Immunotherapy Market growing?

Ans: The Dendritic Cell Cancer Vaccine Immunotherapy Market witnessing a CAGR of 10.1% during the forecast period 2025-2031.

What is the Dendritic Cell Cancer Vaccine Immunotherapy Market size in 2031?

Ans: The Dendritic Cell Cancer Vaccine Immunotherapy Market size in 2031 will be US$ 1446 million.

Who are the main players in the Dendritic Cell Cancer Vaccine Immunotherapy Market report?

Ans: The main players in the Dendritic Cell Cancer Vaccine Immunotherapy Market are Lineage Cell Therapeutics, AVAX Technologies, DCPrime, Gradalis, Heat Biologics, ImmunoCellular Therapeutics, Immunicum, MolecuVax, Northwest Biotherapeutics, Pique Therapeutics, Regeneus, Tessa Therapeutics, Vaccinogen, XEME Biopharma

What are the Application segmentation covered in the Dendritic Cell Cancer Vaccine Immunotherapy Market report?

Ans: The Applications covered in the Dendritic Cell Cancer Vaccine Immunotherapy Market report are Pediatrics, Adults

What are the Type segmentation covered in the Dendritic Cell Cancer Vaccine Immunotherapy Market report?

Ans: The Types covered in the Dendritic Cell Cancer Vaccine Immunotherapy Market report are Provenge, Apceden, CreaVax, Others

Recommended Reports

Cancer Vaccines

Cancer Immunotherapies

Broader Cancer Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Provenge

1.2.3 Apceden

1.2.4 CreaVax

1.2.5 Others

1.3 Market by Application

1.3.1 Global Dendritic Cell Cancer Vaccine Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pediatrics

1.3.3 Adults

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Dendritic Cell Cancer Vaccine Immunotherapy Market Perspective (2020-2031)

2.2 Global Dendritic Cell Cancer Vaccine Immunotherapy Growth Trends by Region

2.2.1 Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Dendritic Cell Cancer Vaccine Immunotherapy Historic Market Size by Region (2020-2025)

2.2.3 Dendritic Cell Cancer Vaccine Immunotherapy Forecasted Market Size by Region (2026-2031)

2.3 Dendritic Cell Cancer Vaccine Immunotherapy Market Dynamics

2.3.1 Dendritic Cell Cancer Vaccine Immunotherapy Industry Trends

2.3.2 Dendritic Cell Cancer Vaccine Immunotherapy Market Drivers

2.3.3 Dendritic Cell Cancer Vaccine Immunotherapy Market Challenges

2.3.4 Dendritic Cell Cancer Vaccine Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Dendritic Cell Cancer Vaccine Immunotherapy Players by Revenue

3.1.1 Global Top Dendritic Cell Cancer Vaccine Immunotherapy Players by Revenue (2020-2025)

3.1.2 Global Dendritic Cell Cancer Vaccine Immunotherapy Revenue Market Share by Players (2020-2025)

3.2 Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Dendritic Cell Cancer Vaccine Immunotherapy Revenue

3.4 Global Dendritic Cell Cancer Vaccine Immunotherapy Market Concentration Ratio

3.4.1 Global Dendritic Cell Cancer Vaccine Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dendritic Cell Cancer Vaccine Immunotherapy Revenue in 2024

3.5 Global Key Players of Dendritic Cell Cancer Vaccine Immunotherapy Head office and Area Served

3.6 Global Key Players of Dendritic Cell Cancer Vaccine Immunotherapy, Product and Application

3.7 Global Key Players of Dendritic Cell Cancer Vaccine Immunotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Dendritic Cell Cancer Vaccine Immunotherapy Breakdown Data by Type

4.1 Global Dendritic Cell Cancer Vaccine Immunotherapy Historic Market Size by Type (2020-2025)

4.2 Global Dendritic Cell Cancer Vaccine Immunotherapy Forecasted Market Size by Type (2026-2031)

5 Dendritic Cell Cancer Vaccine Immunotherapy Breakdown Data by Application

5.1 Global Dendritic Cell Cancer Vaccine Immunotherapy Historic Market Size by Application (2020-2025)

5.2 Global Dendritic Cell Cancer Vaccine Immunotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Dendritic Cell Cancer Vaccine Immunotherapy Market Size (2020-2031)

6.2 North America Dendritic Cell Cancer Vaccine Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025)

6.4 North America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Size (2020-2031)

7.2 Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025)

7.4 Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Size (2020-2031)

8.2 Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Size (2020-2031)

9.2 Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025)

9.4 Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Size (2020-2031)

10.2 Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lineage Cell Therapeutics

11.1.1 Lineage Cell Therapeutics Company Details

11.1.2 Lineage Cell Therapeutics Business Overview

11.1.3 Lineage Cell Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.1.4 Lineage Cell Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.1.5 Lineage Cell Therapeutics Recent Development

11.2 AVAX Technologies

11.2.1 AVAX Technologies Company Details

11.2.2 AVAX Technologies Business Overview

11.2.3 AVAX Technologies Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.2.4 AVAX Technologies Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.2.5 AVAX Technologies Recent Development

11.3 DCPrime

11.3.1 DCPrime Company Details

11.3.2 DCPrime Business Overview

11.3.3 DCPrime Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.3.4 DCPrime Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.3.5 DCPrime Recent Development

11.4 Gradalis

11.4.1 Gradalis Company Details

11.4.2 Gradalis Business Overview

11.4.3 Gradalis Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.4.4 Gradalis Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.4.5 Gradalis Recent Development

11.5 Heat Biologics

11.5.1 Heat Biologics Company Details

11.5.2 Heat Biologics Business Overview

11.5.3 Heat Biologics Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.5.4 Heat Biologics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.5.5 Heat Biologics Recent Development

11.6 ImmunoCellular Therapeutics

11.6.1 ImmunoCellular Therapeutics Company Details

11.6.2 ImmunoCellular Therapeutics Business Overview

11.6.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.6.4 ImmunoCellular Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.6.5 ImmunoCellular Therapeutics Recent Development

11.7 Immunicum

11.7.1 Immunicum Company Details

11.7.2 Immunicum Business Overview

11.7.3 Immunicum Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.7.4 Immunicum Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.7.5 Immunicum Recent Development

11.8 MolecuVax

11.8.1 MolecuVax Company Details

11.8.2 MolecuVax Business Overview

11.8.3 MolecuVax Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.8.4 MolecuVax Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.8.5 MolecuVax Recent Development

11.9 Northwest Biotherapeutics

11.9.1 Northwest Biotherapeutics Company Details

11.9.2 Northwest Biotherapeutics Business Overview

11.9.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.9.4 Northwest Biotherapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.9.5 Northwest Biotherapeutics Recent Development

11.10 Pique Therapeutics

11.10.1 Pique Therapeutics Company Details

11.10.2 Pique Therapeutics Business Overview

11.10.3 Pique Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.10.4 Pique Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.10.5 Pique Therapeutics Recent Development

11.11 Regeneus

11.11.1 Regeneus Company Details

11.11.2 Regeneus Business Overview

11.11.3 Regeneus Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.11.4 Regeneus Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.11.5 Regeneus Recent Development

11.12 Tessa Therapeutics

11.12.1 Tessa Therapeutics Company Details

11.12.2 Tessa Therapeutics Business Overview

11.12.3 Tessa Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.12.4 Tessa Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.12.5 Tessa Therapeutics Recent Development

11.13 Vaccinogen

11.13.1 Vaccinogen Company Details

11.13.2 Vaccinogen Business Overview

11.13.3 Vaccinogen Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.13.4 Vaccinogen Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.13.5 Vaccinogen Recent Development

11.14 XEME Biopharma

11.14.1 XEME Biopharma Company Details

11.14.2 XEME Biopharma Business Overview

11.14.3 XEME Biopharma Dendritic Cell Cancer Vaccine Immunotherapy Introduction

11.14.4 XEME Biopharma Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

11.14.5 XEME Biopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lineage Cell Therapeutics

AVAX Technologies

DCPrime

Gradalis Inc

Heat Biologics

ImmunoCellular Therapeutics

Immunicum

MolecuVax

Northwest Biotherapeutics

Pique Therapeutics

Regeneus

Tessa Therapeutics

Vaccinogen

XEME Biopharma

List of Tables

Table 1. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Provenge

Table 3. Key Players of Apceden

Table 4. Key Players of CreaVax

Table 5. Key Players of Others

Table 6. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Region (2020-2025)

Table 10. Global Dendritic Cell Cancer Vaccine Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Region (2026-2031)

Table 12. Dendritic Cell Cancer Vaccine Immunotherapy Market Trends

Table 13. Dendritic Cell Cancer Vaccine Immunotherapy Market Drivers

Table 14. Dendritic Cell Cancer Vaccine Immunotherapy Market Challenges

Table 15. Dendritic Cell Cancer Vaccine Immunotherapy Market Restraints

Table 16. Global Dendritic Cell Cancer Vaccine Immunotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Players (2020-2025)

Table 18. Global Top Dendritic Cell Cancer Vaccine Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccine Immunotherapy as of 2024)

Table 19. Ranking of Global Top Dendritic Cell Cancer Vaccine Immunotherapy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Dendritic Cell Cancer Vaccine Immunotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Dendritic Cell Cancer Vaccine Immunotherapy, Headquarters and Area Served

Table 22. Global Key Players of Dendritic Cell Cancer Vaccine Immunotherapy, Product and Application

Table 23. Global Key Players of Dendritic Cell Cancer Vaccine Immunotherapy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Dendritic Cell Cancer Vaccine Immunotherapy Revenue Market Share by Type (2020-2025)

Table 27. Global Dendritic Cell Cancer Vaccine Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Dendritic Cell Cancer Vaccine Immunotherapy Revenue Market Share by Type (2026-2031)

Table 29. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Dendritic Cell Cancer Vaccine Immunotherapy Revenue Market Share by Application (2020-2025)

Table 31. Global Dendritic Cell Cancer Vaccine Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Dendritic Cell Cancer Vaccine Immunotherapy Revenue Market Share by Application (2026-2031)

Table 33. North America Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Lineage Cell Therapeutics Company Details

Table 49. Lineage Cell Therapeutics Business Overview

Table 50. Lineage Cell Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 51. Lineage Cell Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 52. Lineage Cell Therapeutics Recent Development

Table 53. AVAX Technologies Company Details

Table 54. AVAX Technologies Business Overview

Table 55. AVAX Technologies Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 56. AVAX Technologies Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 57. AVAX Technologies Recent Development

Table 58. DCPrime Company Details

Table 59. DCPrime Business Overview

Table 60. DCPrime Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 61. DCPrime Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 62. DCPrime Recent Development

Table 63. Gradalis Company Details

Table 64. Gradalis Business Overview

Table 65. Gradalis Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 66. Gradalis Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 67. Gradalis Recent Development

Table 68. Heat Biologics Company Details

Table 69. Heat Biologics Business Overview

Table 70. Heat Biologics Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 71. Heat Biologics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 72. Heat Biologics Recent Development

Table 73. ImmunoCellular Therapeutics Company Details

Table 74. ImmunoCellular Therapeutics Business Overview

Table 75. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 76. ImmunoCellular Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 77. ImmunoCellular Therapeutics Recent Development

Table 78. Immunicum Company Details

Table 79. Immunicum Business Overview

Table 80. Immunicum Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 81. Immunicum Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 82. Immunicum Recent Development

Table 83. MolecuVax Company Details

Table 84. MolecuVax Business Overview

Table 85. MolecuVax Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 86. MolecuVax Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 87. MolecuVax Recent Development

Table 88. Northwest Biotherapeutics Company Details

Table 89. Northwest Biotherapeutics Business Overview

Table 90. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 91. Northwest Biotherapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 92. Northwest Biotherapeutics Recent Development

Table 93. Pique Therapeutics Company Details

Table 94. Pique Therapeutics Business Overview

Table 95. Pique Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 96. Pique Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 97. Pique Therapeutics Recent Development

Table 98. Regeneus Company Details

Table 99. Regeneus Business Overview

Table 100. Regeneus Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 101. Regeneus Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 102. Regeneus Recent Development

Table 103. Tessa Therapeutics Company Details

Table 104. Tessa Therapeutics Business Overview

Table 105. Tessa Therapeutics Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 106. Tessa Therapeutics Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 107. Tessa Therapeutics Recent Development

Table 108. Vaccinogen Company Details

Table 109. Vaccinogen Business Overview

Table 110. Vaccinogen Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 111. Vaccinogen Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 112. Vaccinogen Recent Development

Table 113. XEME Biopharma Company Details

Table 114. XEME Biopharma Business Overview

Table 115. XEME Biopharma Dendritic Cell Cancer Vaccine Immunotherapy Product

Table 116. XEME Biopharma Revenue in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025) & (US$ Million)

Table 117. XEME Biopharma Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Dendritic Cell Cancer Vaccine Immunotherapy Picture

Figure 2. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Type: 2024 VS 2031

Figure 4. Provenge Features

Figure 5. Apceden Features

Figure 6. CreaVax Features

Figure 7. Others Features

Figure 8. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Application: 2024 VS 2031

Figure 10. Pediatrics Case Studies

Figure 11. Adults Case Studies

Figure 12. Dendritic Cell Cancer Vaccine Immunotherapy Report Years Considered

Figure 13. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Region: 2024 VS 2031

Figure 16. Global Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Players in 2024

Figure 17. Global Top Dendritic Cell Cancer Vaccine Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccine Immunotherapy as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Immunotherapy Revenue in 2024

Figure 19. North America Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Country (2020-2031)

Figure 21. United States Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Country (2020-2031)

Figure 25. Germany Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Region (2020-2031)

Figure 33. China Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Country (2020-2031)

Figure 41. Mexico Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Dendritic Cell Cancer Vaccine Immunotherapy Market Share by Country (2020-2031)

Figure 45. Turkey Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Dendritic Cell Cancer Vaccine Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Lineage Cell Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 49. AVAX Technologies Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 50. DCPrime Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 51. Gradalis Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 52. Heat Biologics Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 53. ImmunoCellular Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 54. Immunicum Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 55. MolecuVax Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 56. Northwest Biotherapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 57. Pique Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 58. Regeneus Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 59. Tessa Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 60. Vaccinogen Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 61. XEME Biopharma Revenue Growth Rate in Dendritic Cell Cancer Vaccine Immunotherapy Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Research Report 2024

Global Immune Checkpoint Proteins Market Research Report 2024

Global Tumor Immune Cell Therapy Market Research Report 2024

Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Immunotherapy Platform Market Research Report 2024

Global Immuno Cell Therapy Market Research Report 2024

Global CD Antigen Cancer Therapy Market Research Report 2025

Tumour cell Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circulating Tumor Cells CTCs Detectors Market Research Report 2024

Global T Cell Activation Market Research Report 2024

Global Peptide Based Vaccines for Cancer Market Research Report 2025

Global TIL Cell Therapy Market Research Report 2025

Global Checkpoint Inhibitors for Treating Cancer Market Insights Forecast to 2030

Global Dendritic Cell Vaccine Market Research Report 2025

Global Natural Killer Cell Therapeutics Market Research Report 2024

Global Immune Checkpoint Inhibitors for Cancer Market Research Report 2024

Global Cytotoxic T Cells CTL Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions